"Schizophrenic Psychology" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Study of mental processes and behavior of schizophrenics.
| Descriptor ID |
D012565
|
| MeSH Number(s) |
F04.824
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Schizophrenic Psychology".
Below are MeSH descriptors whose meaning is more specific than "Schizophrenic Psychology".
This graph shows the total number of publications written about "Schizophrenic Psychology" by people in this website by year, and whether "Schizophrenic Psychology" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 3 | 3 |
| 2000 | 1 | 0 | 1 |
| 2002 | 3 | 2 | 5 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 2 | 3 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 2 | 2 |
| 2012 | 10 | 1 | 11 |
| 2013 | 8 | 1 | 9 |
| 2014 | 2 | 1 | 3 |
| 2015 | 1 | 1 | 2 |
| 2016 | 5 | 1 | 6 |
| 2017 | 0 | 1 | 1 |
| 2018 | 2 | 1 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Schizophrenic Psychology" by people in Profiles.
-
Cognitive Deficits and Clinical Symptoms with Hippocampal Subfields in First-Episode and Never-Treated Patients with Schizophrenia. Cereb Cortex. 2021 01 01; 31(1):89-96.
-
Food Refusal Secondary to Psychosis: A Case Series and Literature Review. J Nerv Ment Dis. 2020 09; 208(9):654-657.
-
Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels. Prog Neuropsychopharmacol Biol Psychiatry. 2018 07 13; 85:69-76.
-
Interleukin-3, symptoms and cognitive deficits in first-episode drug-na?ve and chronic medicated schizophrenia. Psychiatry Res. 2018 05; 263:147-153.
-
Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disorders. Psychiatry Res. 2018 03; 261:248-252.
-
Prevalence, demographic and clinical features of comorbid depressive symptoms in drug na?ve patients with schizophrenia presenting with first episode psychosis. Schizophr Res. 2018 03; 193:182-187.
-
Stigma and discrimination experienced by people with schizophrenia living in the community in Guangzhou, China. Psychiatry Res. 2017 09; 255:225-231.
-
Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting. Ann Clin Psychiatry. 2017 05; 29(2):92-107.
-
The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia. Psychiatry Res. 2017 May; 251:131-136.
-
A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder. Psychiatr Q. 2016 12; 87(4):729-737.